Product Description: Ifinatamab is monoclonal immunoglobulin G1-kappa with anti-human B7 homolog 3 protein (Human B7-H3). Ifinatamab is a glycoforme α immunomodulateur[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]WHO Drug Information. International Nonproprietary Names for Pharmaceutical.